Evaluation of Biomarkers of Severity in Patients with COVID-19 Infection.

Akitaka YamamotoHideo WadaYuhuko IchikawaHikaru MizunoMasaki TomidaJun MasudaKatsutoshi MakinoShuji KodamaMasamichi YoshidaShunsuke FukuiIsao MoritaniHidekazu InoueKatsuya ShirakiHideto Shimpo

Published in: Journal of clinical medicine (2021)

The evaluation of severity is valuable, as the mortality rate was high in the moderate II and severe stages. The levels of CRP, ferritin, PCT, albumin, and LDH were useful markers of severity, and hemostatic abnormalities were frequently observed in patients in the severe disease stage.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
early onset
prognostic factors
cardiovascular events
high intensity
cardiovascular disease
risk factors
coronary artery disease